A New Blueprint For Technology Transfer

By Stuart Ward, Director, Platform & Solutions, IDBS

Technology transfer is a necessary evil that exists between drug development and manufacturing, but information sharing is disjointed. Fortunately, life science experts are optimistic about the future of technology transfer and reducing the amount of time and money it requires. Sophisticated technology already exists that can help draw “a new blueprint” for technology transfer built around data integrity.

Ensuring a two-way communication between development and manufacturing about process and product knowledge is a large step toward improvement that can be achieved with digital processes that contextualize data. Learn more about how leveraging contextual data on how process and product interact can help you efficiently execute processes while curating necessary data.